for everything you said requires management and board who is interested to work hard to get this product world wide ... IMO....!
if and when management particularly CEO & Chairman is replaced with someone new who has that energy & vision to take this company to next level then probably company has better prospect... IMO.
- Forums
- ASX - By Stock
- AVH
- Webinar
Webinar, page-37
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.86 |
Change
0.100(3.62%) |
Mkt cap ! $187.9M |
Open | High | Low | Value | Volume |
$2.84 | $2.92 | $2.84 | $190.3K | 66.50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3896 | $2.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.88 | 7412 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3481 | 2.870 |
1 | 3693 | 2.850 |
1 | 7641 | 2.840 |
1 | 2000 | 2.830 |
1 | 3511 | 2.820 |
Price($) | Vol. | No. |
---|---|---|
2.890 | 1194 | 2 |
2.900 | 2033 | 5 |
2.910 | 1515 | 1 |
2.920 | 2580 | 2 |
2.930 | 13402 | 3 |
Last trade - 10.05am 16/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online